WallStreetZenWallStreetZen

NYSE: GMRE
Global Medical Reit Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for GMRE

Based on 2 analysts offering 12 month price targets for Global Medical Reit Inc

Min Forecast
$40.00+9.77%
Avg Forecast
$40.50+11.14%
Max Forecast
$41.00+12.51%

Should I buy or sell GMRE stock?

Based on 2 analysts offering ratings for Global Medical Reit Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 50%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although GMRE's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates GMRE as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More

Be the first to know when Wall Street analysts revise their GMRE stock forecasts and price targets.

GMRE stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-11-11
lockedlocked$00.00+00.00%2025-10-13

1 of 1

Forecast return on equity

Is GMRE forecast to generate an efficient return?

Company
N/A
Industry
6.36%
Market
241.9%

Forecast return on assets

Is GMRE forecast to generate an efficient return on assets?

Company
N/A
Industry
3.75%

GMRE earnings per share forecast

What is GMRE's earnings per share in the next 2 years based on estimates from 5 analysts?

Avg 1 year Forecast
$0.23
Avg 2 year Forecast
$0.41

GMRE revenue forecast

What is GMRE's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$153.9M+6.15%
Avg 2 year Forecast
$159.4M+9.95%
Avg 3 year Forecast
$161.5M+11.38%
GMRE's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

GMRE revenue growth forecast

How is GMRE forecast to perform vs REIT - Healthcare Facilities companies and vs the US market?

Company
4.49%
Industry
13.69%
Market
57.89%
GMRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
GMRE's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

GMRE vs Healthcare Facility REIT Stocks

TickerPricePrice TargetUp/downsideConsensus
GMRE$36.44$40.50+11.14%Buy
CHCT$17.96$20.00+11.36%Strong Buy
UHT$42.45N/AN/A
STRW$12.50$14.00+12.00%Strong Buy
SILA$25.16$26.00+3.34%Buy
View Top Healthcare Facility REIT Stocks

Global Medical Reit Stock Forecast FAQ

Is Global Medical Reit Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NYSE: GMRE) stock is to Buy GMRE stock.

Out of 2 analysts, 0 (0%) are recommending GMRE as a Strong Buy, 1 (50%) are recommending GMRE as a Buy, 1 (50%) are recommending GMRE as a Hold, 0 (0%) are recommending GMRE as a Sell, and 0 (0%) are recommending GMRE as a Strong Sell.

If you're new to stock investing, here's how to buy Global Medical Reit stock.

What is GMRE's earnings growth forecast for 2026-2027?

(NYSE: GMRE) Global Medical Reit's forecast annual earnings growth rate of N/A is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast earnings growth rate of 39.21%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 102.38%.

Global Medical Reit's earnings in 2026 is -$3,323,000.On average, 5 Wall Street analysts forecast GMRE's earnings for 2026 to be $3,145,366, with the lowest GMRE earnings forecast at $788,353, and the highest GMRE earnings forecast at $5,631,090.

In 2027, GMRE is forecast to generate $5,470,202 in earnings, with the lowest earnings forecast at $5,255,684 and the highest earnings forecast at $5,631,090.

What is GMRE's revenue growth forecast for 2026-2028?

(NYSE: GMRE) Global Medical Reit's forecast annual revenue growth rate of 4.49% is not forecast to beat the US REIT - Healthcare Facilities industry's average forecast revenue growth rate of 13.69%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 57.89%.

Global Medical Reit's revenue in 2026 is $144,972,000.On average, 9 Wall Street analysts forecast GMRE's revenue for 2026 to be $2,063,258,323, with the lowest GMRE revenue forecast at $1,957,742,415, and the highest GMRE revenue forecast at $2,167,031,274. On average, 6 Wall Street analysts forecast GMRE's revenue for 2027 to be $2,137,132,865, with the lowest GMRE revenue forecast at $1,976,110,496, and the highest GMRE revenue forecast at $2,331,941,777.

In 2028, GMRE is forecast to generate $2,164,886,096 in revenue, with the lowest revenue forecast at $2,051,057,627 and the highest revenue forecast at $2,259,676,117.

What is GMRE's forecast return on assets (ROA) for 2026-2028?

(NYSE: GMRE) forecast ROA is N/A, which is lower than the forecast US REIT - Healthcare Facilities industry average of 3.75%.

What is GMRE's Price Target?

According to 2 Wall Street analysts that have issued a 1 year GMRE price target, the average GMRE price target is $40.50, with the highest GMRE stock price forecast at $41.00 and the lowest GMRE stock price forecast at $40.00.

On average, Wall Street analysts predict that Global Medical Reit's share price could reach $40.50 by Nov 11, 2026. The average Global Medical Reit stock price prediction forecasts a potential upside of 11.14% from the current GMRE share price of $36.44.

What is GMRE's Earnings Per Share (EPS) forecast for 2026-2027?

(NYSE: GMRE) Global Medical Reit's current Earnings Per Share (EPS) is -$0.25. On average, analysts forecast that GMRE's EPS will be $0.23 for 2026, with the lowest EPS forecast at $0.06, and the highest EPS forecast at $0.42. In 2027, GMRE's EPS is forecast to hit $0.41 (min: $0.39, max: $0.42).

What is GMRE's forecast return on equity (ROE) for 2026-2028?

(NYSE: GMRE) forecast ROE is N/A, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.